(ISO) Technical Pivots with Risk Controls (ISO:CA)

IsoEnergy (ISOU, ISO) and DISA Technologies completed a transaction to form DISA Uranium, combining IsoEnergy's Utah uranium mines with DISA's HPSA technology. IsoEnergy received 1.68M shares and invested $33M in a $105M financing, now owning 33% of DISA Uranium. The new company plans to focus on uranium recovery and production using its technology and existing assets.

DISA Technologies formed DISA Uranium to remediate abandoned uranium mine waste and produce domestic uranium, citing the only NRC license for such recovery. It agreed to acquire IsoEnergy’s Utah uranium portfolio, including Tony M Mine, for a scaled conventional resource base. DISA Uranium secured commitments for a $105 million private placement, with closing expected Aug 2026.

IsoEnergy Ltd. said shareholders approved all resolutions at its June 10, 2026 virtual annual general meeting, with 38,225,097 common shares represented (63.05% of issued shares). The six director nominees were elected and KPMG LLP was reappointed auditor. In the Toro Energy deal, Toro shareholders approved the scheme on June 9 (92.89% in favor), pending a June 15 Federal Court hearing and remaining conditions.

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.